8-KEarnings & ResultsExhibits & Filings

BeOne Medicines Ltd. 8-K Report, Financial Results (Aug 5, 2026)

Filed August 5, 2026For Securities:ONCBEIGF

Summary

BeOne Medicines Ltd. (ONC) has filed an 8-K report on August 5, 2026, primarily announcing its financial results for the second quarter ended June 30, 2026. The report includes a press release detailing these financial outcomes and any associated business updates. Investors should refer to Exhibit 99.1 for the specific details of the financial performance and operational progress during the second quarter of 2026. While the 8-K itself is brief and focuses on the disclosure of the press release, the attached document is crucial for understanding the company's current financial health and strategic direction. The filing emphasizes that the information presented in the press release, as furnished under Item 2.02, is not considered 'filed' for certain regulatory purposes, a standard disclaimer for such announcements.

Key Highlights

  • 1BeOne Medicines Ltd. announced its Q2 2026 financial results and business updates on August 5, 2026.
  • 2The company filed a Form 8-K to report these financial results and updates.
  • 3The press release detailing the Q2 2026 performance is attached as Exhibit 99.1.
  • 4Investors are directed to Exhibit 99.1 for comprehensive financial and operational details.
  • 5The filing includes standard SEC disclaimers regarding the furnished information.
  • 6The report covers the three-month period ending June 30, 2026.

Frequently Asked Questions

The detailed financial results and business updates for the second quarter ended June 30, 2026, are available in the press release attached as Exhibit 99.1 to this Form 8-K filing.

The information furnished under Item 2.02 of an 8-K, as is the case with the press release, is generally not subject to the same liabilities under Section 18 of the Exchange Act as information that is formally 'filed'. It also isn't automatically incorporated by reference into other filings unless specifically stated.

This 8-K filing itself does not contain the specific financial figures. It serves as a notification that these details are provided in the attached press release (Exhibit 99.1), which investors should consult for quantitative financial data.